Genvor Amends 8-K, Cites Non-Reliance on Past Financials
Ticker: GNVR · Form: 8-K/A · Filed: Jan 18, 2024 · CIK: 1792941
| Field | Detail |
|---|---|
| Company | Genvor Inc (GNVR) |
| Form Type | 8-K/A |
| Filed Date | Jan 18, 2024 |
| Risk Level | high |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $246,000 |
| Sentiment | bearish |
Complexity: simple
Sentiment: bearish
Topics: financial-restatement, accounting-issues, 8-K/A, corporate-governance
TL;DR
**Genvor just admitted its old financials can't be trusted.**
AI Summary
Genvor Inc. filed an 8-K/A on January 18, 2024, amending a previous report from January 9, 2024. This amendment specifically addresses the company's non-reliance on previously issued financial statements or related audit reports. This matters to investors because it signals potential inaccuracies in past financial disclosures, which could impact the perceived value and trustworthiness of the company's stock.
Why It Matters
This filing indicates that Genvor Inc. is retracting or disclaiming previous financial statements, which can erode investor confidence and lead to a re-evaluation of the company's financial health.
Risk Assessment
Risk Level: high — Non-reliance on financial statements is a serious red flag, indicating potential material misstatements or accounting errors that could significantly impact the company's valuation.
Analyst Insight
A smart investor would view this non-reliance on past financials as a significant warning sign, prompting a deeper investigation into the nature and extent of the financial inaccuracies before making any investment decisions, or considering divesting if already holding shares.
Key Players & Entities
- Genvor Inc. (company) — the registrant filing the 8-K/A
- Nevada (company) — state of incorporation for Genvor Inc.
- Allure Worldwide, Inc. (company) — Genvor Inc.'s former company name
- January 9, 2024 (date) — date of the earliest event reported in the filing
- January 18, 2024 (date) — date the 8-K/A was filed
FAQ
What is the primary purpose of Genvor Inc.'s 8-K/A filing dated January 18, 2024?
The primary purpose of Genvor Inc.'s 8-K/A filing is to amend a previous report and disclose the company's non-reliance on previously issued financial statements or a related audit report or completed interim review, as stated under 'ITEM INFORMATION: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review'.
What was Genvor Inc.'s former company name and when did the name change occur?
Genvor Inc.'s former company name was Allure Worldwide, Inc., and the date of the name change was 20191031 (October 31, 2019), as indicated in the 'FORMER COMPANY' section of the filing.
What is Genvor Inc.'s business address and phone number?
Genvor Inc.'s business address is 201 S. Elliott Road, Suite 538, Chapel Hill, NC 27514, and its business phone number is (984) 261-7338, as listed in the 'BUSINESS ADDRESS' section.
What is the Central Index Key (CIK) for Genvor Inc.?
The Central Index Key (CIK) for Genvor Inc. is 0001792941, as found in the 'COMPANY DATA' section of the filing.
Does Genvor Inc. have any securities registered pursuant to Section 12(b) of the Act?
No, Genvor Inc. does not have any securities registered pursuant to Section 12(b) of the Act, as explicitly stated: 'Securities registered pursuant to Section 12(b) of the Act: None. Title of each class N/A Trading Symbol(s) N/A Name of each exchange on which registered N/A'.
Filing Stats: 688 words · 3 min read · ~2 pages · Grade level 12.5 · Accepted 2024-01-18 17:14:11
Key Financial Figures
- $246,000 — abilities and net loss by approximately $246,000 as of the periods indicated. The Compan
Filing Documents
- form8-ka.htm (8-K/A) — 39KB
- ex7-1.htm (EX-7.1) — 5KB
- ex7-1_001.jpg (GRAPHIC) — 28KB
- 0001493152-24-002926.txt ( ) — 251KB
- gen-20240109.xsd (EX-101.SCH) — 3KB
- gen-20240109_lab.xml (EX-101.LAB) — 33KB
- gen-20240109_pre.xml (EX-101.PRE) — 22KB
- form8-ka_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GENVOR INCORPORATED Dated: January 18, 2024 By: /s/ Chad Pawlak Chad Pawlak Chief Executive Officer